Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Comet reported first-half 2026 revenues of CHF240 million, a 5.6% increase year-over-year on a reported basis and 12.7% organically. Reported EBITDA was CHF31 million (13.1% margin), above consensus, while net income rose to CHF14 million despite higher tax charges. The group provided formal guidance for fiscal 2026, forecasting sales of CHF540-570…
Costamare Bulkers Holdings Limited, an international owner and operator of dry bulk vessels, announced that it will release its second quarter 2026 financial results on August 3, 2026 before the market opens. The company operates a fleet of 30 dry bulk vessels and manages an operating platform involved in chartering and freight contracts. The annou…
The bipartisan Russia sanctions bill, once championed by the late Senator Lindsey Graham, faces significant opposition over a provision that would authorize the president to impose steep tariffs - including 100% duties - on major importers of Russian energy or states deemed to aid sanctions evasion. While the measure could pass the Senate, Democrat…
Bank of Ireland reported first-half 2026 pre-tax profit that outpaced consensus by 19%, helped by substantially lower impairments and valuation gains. The lender also raised its net interest income and return-on-equity targets for 2026 and adjusted guidance for subsequent years while maintaining a CET1 ratio in line with expectations.
AeroVironment (AVAV) has been punished on program stops and litigation headlines, but balance-sheet resilience, a steady pipeline of counter-UAS and loitering munition contracts, and improving technicals suggest the bottom may be forming. This trade idea outlines a disciplined long with entry at current levels, a stop below the recent low, and a ta…
President Donald Trump will host a Cabinet meeting at Camp David on Friday, a rare retreat visit in his second term, as his administration contends with an ongoing military exchange with Iran and rising gasoline prices. The confrontation has entered its fifth month and public backing for the conflict has fallen to about one in three Americans, incr…
Replimune stock jumped 125.3% in pre-market trading after the FDA's Cellular, Tissue, and Gene Therapies Advisory Committee voted 10 to 3 in favor of the efficacy data from the company's IGNYTE trial of RP1 (vusolimogene oderparepvec) combined with nivolumab for advanced melanoma patients who progressed on prior anti-PD-1 therapy. The panel found t…
A dramatic rotation in AI-related shares, renewed Middle East hostilities and severe European wildfires combine to create a high-risk backdrop for markets this week. Key data points include forthcoming U.S. non-farm payrolls that could sway Federal Reserve policy, and a Reserve Bank of India decision as authorities try to stabilise the rupee amid r…
IonQ's headline metrics look frothy, but two questions - can the company sustain hyper-growth in commercial quantum services and does it have a cash runway to get there - have answers that justify a tactical long. Strong top-line momentum, a $3.0B cash war chest and improving technicals make this a high-risk, high-reward long idea with defined risk…
JD.com will release its unaudited financial results for Q2 and the first half of 2026 on August 13, 2026, prior to the U.S. market opening. Management will hold a conference call to discuss the results, with access details provided for investors and media. The company highlights its role as a leading supply chain-based technology and service provid…
Patria Investments Limited reported a strong second quarter 2026 performance highlighted by $2.3 billion raised in new funds during the quarter, a 24% year-over-year increase in Fee-Related Earnings to $57.1 million, and a 31% rise in Distributable Earnings per share to $0.32. The company is on track to meet full-year financial guidance and declare…
Titan Mining Corporation, a U.S.-focused critical minerals producer known for zinc and natural flake graphite, will release its Q2 2026 financial results before market open on August 12, 2026, followed by a webcasted corporate update. The company highlights its role in strengthening domestic critical minerals supply chains and ongoing operational a…
Perimeter Solutions, Inc. reported its financial results for Q2 2026, showing a 31% increase in net sales driven by growth in Fire Safety and Specialty Products segments. The company recorded a significant net loss of $181.6 million largely due to related party founders advisory fees and acquisition costs, but achieved an adjusted net income of $59…
BrightSpring Health Services, Inc. announced robust second quarter 2026 financial results, including a 23% increase in net revenue to $3.873 billion and a 44% rise in adjusted EBITDA to $206 million. The company also raised its full-year 2026 revenue and adjusted EBITDA guidance, projecting revenue growth of 17.0% to 19.5% and adjusted EBITDA growt…
Fortis Inc. released its Q2 2026 financial results showing net earnings of $396 million ($0.78/share), up from $384 million in 2025. The company is progressing on its $5.6 billion annual capital plan with key projects including the completion of the Roadrunner Reserve II battery storage and the approval of the Tilbury 1B LNG facility expansion in B…
Eastman Chemical (EMN) reported the kind of operational resilience that matters for a cyclical specialty-chemicals name: solid free cash flow, a manageable balance sheet, and pricing power from regional feedstock tightness tied to Middle East supply disruptions. At a market cap just over $8.0B and EV/EBITDA near 9.2x, the stock looks reasonably val…
Viridien's stock climbed 14.7% after the company reported Q2 2026 results that showed a sizable increase in its geoscience backlog to $306 million and a 60% adjusted EBITDA margin in its Earth Data Analytics segment. Management kept its full-year 2026 net cash flow target of $100 million, and an interim financial filing with the Autorité des Marché…
Corbion's stock fell after the Amsterdam-listed ingredients maker reported H1 2026 results and reduced its adjusted EBITDA margin target for the year to above 16% from around 17%. Management blamed a mix of macroeconomic uncertainty and unexpected cost inflation related to the ongoing Middle East conflict, which lifted raw material, freight and ene…
Konica Minolta's stock dropped to the daily limit, trading at ¥590.8 after investors concluded that reported Q1 FY2027 results were flattered by non-recurring items. While business contribution profit rose 26% to ¥11.6 billion and sales of ¥258.5 billion beat estimates, about ¥7.4 billion of that profit gain came from U.S. tariff refunds and a weak…
Shares in CVS Group rose after Barclays moved the stock to overweight and lifted its price target, pointing to management disclosures showing strong returns from the chain’s Australian acquisition programme and a multi-hundred-million-pound EBITDA ambition for the unit. Barclays’ analysis also flags a pipeline of potential sites and improved acquis…
Nomura Research Institute reported first quarter fiscal 2027 results that beat Visible Alpha consensus on revenue and met operating profit estimates, yet the stock plunged after investors reacted to divergent segment performance and no change to full-year guidance.Sales rose to ¥210.5 billion, up 7.5% year-on-year, and operating profit climbed to ¥…
Kioxia's stock climbed sharply after the company posted a blockbuster fiscal first quarter driven by higher NAND prices, stronger AI data-center demand, expanded bit shipments and a weaker yen. Management approved a 3-for-1 stock split and an ¥800 billion buyback while reporting a net cash position. The Q1 operating profit and the ¥1.89 trillion Q2…
Synchrony Financial is cheap on P/E and P/B, returning capital aggressively via a $6.5B buyback that could retire roughly 25% of the company by market-cap terms. Credit metrics are improving and loan losses are trending down. This trade plan targets upside to $86 with a $70 stop, sized for a long-term (180 trading days) holding period.
Abivax shares climbed after the company said it had completed a pre-New Drug Application meeting with the U.S. Food and Drug Administration for obefazimod, its lead ulcerative colitis candidate. The FDA signaled full alignment on the planned NDA submission strategy and the dossier's content and format, removing a key procedural uncertainty. Abivax …
Magna International shares climbed in pre-market trading after the automotive supplier reported record second-quarter results that outpaced analyst expectations, raised its full-year 2026 outlook and delivered robust cash generation and shareholder returns. The company also benefited from an improved credit outlook from S&P Global Ratings. Together…
